TWD 72.7
(-0.41%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 9.87 Billion TWD | 2.86% |
2022 | 9.6 Billion TWD | 3.27% |
2021 | 9.29 Billion TWD | -0.69% |
2020 | 9.36 Billion TWD | -2.01% |
2019 | 9.55 Billion TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 10.24 Billion TWD | 1.74% |
2024 Q1 | 10.07 Billion TWD | 2.02% |
2023 Q4 | 9.87 Billion TWD | -0.82% |
2023 FY | 9.87 Billion TWD | 2.86% |
2023 Q1 | 9.56 Billion TWD | -0.36% |
2023 Q3 | 9.95 Billion TWD | 3.34% |
2023 Q2 | 9.63 Billion TWD | 0.73% |
2022 Q4 | 9.6 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | -375.006% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -740.15% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | -713.564% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 15.805% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 8.665% |
Center Laboratories, Inc. | 27 Billion TWD | 63.429% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -1409.844% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | -285.336% |
InnoPharmax Inc. | 524.19 Million TWD | -1783.82% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | -395.494% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | -526.053% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | -444.779% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | -430.497% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | -225.133% |
UniPharma Co., Ltd. | 350.07 Million TWD | -2720.806% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | -345.101% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | -914.678% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -1131.629% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -2154.159% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -1719.763% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | -605.422% |